AdvisorShares Trust AdvisorShares Pure US Cannabis ETF (MSOS)
3.0700
0.00 (0.00%)

AdvisorShares launched HVAC & Industrials ETF on Feb. 4, investing in HVAC & industrial companies for long-term growth. Portfolio includes ADRs.
Via Benzinga · February 6, 2025

Via The Motley Fool · January 22, 2025

Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions.
Via Benzinga · January 15, 2025

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness.
Via Benzinga · January 8, 2025

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Via Benzinga · January 8, 2025

MSOS rose over 14% in today’s session. Interestingly, the price action was inside the trading range of Monday.
Via Talk Markets · November 12, 2024

Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.
Via Benzinga · January 3, 2025

Via The Motley Fool · December 31, 2024

In 2024, the cannabis landscape in the U.S. experienced some developments, though federal legalization or removal from the CSA.
Via Benzinga · December 27, 2024

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.
Via Benzinga · December 4, 2024

The AdvisorShares Pure US Cannabis ETF (NYSEMSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.
Via Benzinga · November 21, 2024
Markets opened with a strong tailwind, driven by the latest CPI data showing inflation in line with expectations, bolstering investor confidence.
Via Talk Markets · November 13, 2024

Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.
Via Benzinga · November 13, 2024

Matt Gaetz has been named the attorney general nominee by Donald Trump. The selection comes while Gaetz is being investigated by Congress.
Via Benzinga · November 13, 2024

Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.
Via Benzinga · November 12, 2024

What’s promised on the campaign trail and what comes to reality are often different. But that didn’t stop investors and traders from speculating on the most prevalent themes under a new administration. Here's a look at what moved and why.
Via Talk Markets · November 10, 2024

After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip?
Via Benzinga · November 7, 2024

Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.
Via Benzinga · November 6, 2024

Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.
Via Benzinga · November 6, 2024

Florida and the Dakotas reject cannabis measures, while Nebraska approves medical cannabis and Dallas decriminalizes. Explore each state's path forward.
Via Benzinga · November 6, 2024

Federal reform and banking access may drive cannabis capital markets in 2025. Discover why upcoming election changes could boost the industry.
Via Benzinga · November 4, 2024

Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.
Via Benzinga · October 31, 2024

AdvisorShares MSOS ETF surges 8% as U.S. cannabis reform nears. Explore key investment signals and market opportunities.
Via Benzinga · October 23, 2024

Cannabis leaders at the Benzinga Cannabis Capital Conference see rescheduling and banking reform as game-changers for the industry.
Via Benzinga · October 11, 2024

Marijuana companies would be "treated like normal businesses," If the oppressive restrictions of Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting typical business expenses, go away.
Via Benzinga · October 8, 2024